Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Modeling of a hyper-inflammatory hematopoietic niche ex vivo reveals a multi-step process driving CAR T- cell associated myeloid leukemia in multiple myeloma

Blood (2025) 146 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2025-2152

Published: 2025

Journal Articles

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma

Blood (2025) 146 (Supplement 1): 7465.

https://doi.org/10.1182/blood-2025-7465

Published: 2025

Journal Articles

NQO1 modulates CD38 surface expression in multiple myeloma

Seungbin Han, Christina Verbruggen, Silvia Nerreter, Umair Munawar, Shilpa Kurian, Emma Besant, Ann-Sophie Hainold, Cornelia Vogt, Xiang Zhou, Hermann Einsele, Leo Rasche, Markus Sauer, Johannes Waldschmidt, K. Martin Kortüm

Blood (2025) 146 (Supplement 1): 5718.

https://doi.org/10.1182/blood-2025-5718

Published: 2025

Journal Articles

Talquetamab alters T cell transcriptome in presence of GPRC5D on MM cells

Umair Munawar, Alexander Leipold, Silvia Nerreter, Seungbin Han, Shilpa Kurian, Emma Besant, Nina Rein, Max Koeppel, Johanna Lehmann, Xiang Zhou, Hermann Einsele, Leo Rasche, Emmanuel Saliba, Johannes Waldschmidt, K. Martin Kortüm

Blood (2025) 146 (Supplement 1): 5701.

https://doi.org/10.1182/blood-2025-5701

Published: 2025

Journal Articles

Lattice light-sheet microscopy reveals patient specific responses to CD20-directed antibodies in B cell malignancies

Julia Weingart, Patrick Eiring, Umair Munawar, Seungbin Han, Christina Verbruggen, Silvia Nerreter, Shilpa Kurian, Max Steinhardt, Leo Rasche, Hermann Einsele, Johannes Waldschmidt, K. Martin Kortüm, Markus Sauer

Blood (2025) 146 (Supplement 1): 4343.

https://doi.org/10.1182/blood-2025-4343

Published: 2025

Journal Articles

An acquired immune-metabolic shift to common chemotherapy confers resistance to immunotherapies in relapsed, high-risk multiple myeloma

Blood (2025) 146 (Supplement 1): 3938.

https://doi.org/10.1182/blood-2025-3938

Published: 2025

Journal Articles

Impact of bortezomib on T-cell subsets and immune checkpoints under bispecific antibody therapy in multiple myeloma

Xiang Zhou, Umair Munawar, Shilpa Kurian, Seungbin Han, Mara John, Hanna Fischer, Silvia Nerreter, Lenka Besse, Andrej Besse, Christoph Driessen, Marc Schmalzing, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, K. Martin Kortüm

Blood (2025) 146 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2025-2174

Published: 2025

Journal Articles

Novel insights in therapeutic antibody therapies using advanced microscopy techniques

Christina Verbruggen, Patrick Eiring, Max Steinhardt, Julia Weingart, Umair Munawar, Seungbin Han, Sven Neubert, Emma Besant, Cornelia Vogt, Silvia Nerreter, Shilpa Kurian, Nina Rein, Johanna Lehmann, Max Koeppel, Hermann Einsele, Johannes Waldschmidt, Markus Sauer, K. Martin Kortüm

Blood (2025) 146 (Supplement 1): 6111.

https://doi.org/10.1182/blood-2025-6111

Published: 2025

Journal Articles

Upregulation of BCMA expression by selinexor

Christina Verbruggen, Umair Munawar, Seungbin Han, Julia Mersi, Emma Besant, Shilpa Kurian, Silvia Nerreter, Nina Rein, Johanna Lehmann, Max Koeppel, Hermann Einsele, Leo Rasche, Johannes Waldschmidt, K. Martin Kortüm

Blood (2025) 146 (Supplement 1): 6102.

https://doi.org/10.1182/blood-2025-6102

Published: 2025

Journal Articles

Elevated NQO1 expression mediates proteasome inhibitor resistance and predicts adverse outcomes in multiple myeloma

Blood (2025) 146 (Supplement 1): 6812.

https://doi.org/10.1182/blood-2025-6812

Published: 2025

Journal Articles

Implementing Hifi Sequencing for Enhanced Genomic and Methylome Characterization in Multiple Myeloma

Seungbin Han, Nazia Afrin, Bas Tolhuis, Marietta Truger, Peter Raab, Umair Munawar, Cornelia Vogt, Shilpa Kurian, Silvia Nerreter, Xiang Zhou, Claudia Haferlach, Hermann Einsele, Johannes Waldschmidt, Leo Rasche, K. Martin Kortüm

Blood (2024) 144 (Supplement 1): 7490.

https://doi.org/10.1182/blood-2024-207422

Published: 2024

Journal Articles

Multi-Omics Analysis of Proteasome Inhibitor Resistance in Multiple Myeloma

Seungbin Han, Chien-Yun Lee, Lenka Besse, Umair Munawar, Andrej Besse, Ann-Sohpie Hainold, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Xiang Zhou, Larissa Haertle, Johannes Waldschmidt, Christoph Driessen, Hermann Einsele, Leo Rasche, Bernhard Kuster, K. Martin Kortüm

Blood (2024) 144 (Supplement 1): 6817.

https://doi.org/10.1182/blood-2024-203352

Published: 2024

Journal Articles

GPRC5D Status Impacts CD38 Expression in Multiple Myeloma

Umair Munawar, Julia Weingart, Patrick Eiring, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Seungbin Han, Max J Steinhardt, Xiang Zhou, Markus Sauer, Hermann Einsele, Leo Rasche, Johannes Waldschmidt, K. Martin Kortüm

Blood (2024) 144 (Supplement 1): 3267.

https://doi.org/10.1182/blood-2024-204863

Published: 2024

Journal Articles

Bi-Allelic GPRC5D Alterations Provide Proliferative Advantage in Presence of Talquetamab

Umair Munawar, Seungbin Han, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Patrick Eiring, Julia Weingart, Xiang Zhou, Markus Sauer, Hermann Einsele, Leo Rasche, Johannes Waldschmidt, K. Martin Kortüm

Blood (2024) 144 (Supplement 1): 593.

https://doi.org/10.1182/blood-2024-200593

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Modeling of a hyper-inflammatory hematopoietic niche ex vivo reveals a multi-step process driving CAR T- cell associated myeloid leukemia in multiple myeloma

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma

NQO1 modulates CD38 surface expression in multiple myeloma

Talquetamab alters T cell transcriptome in presence of GPRC5D on MM cells

Lattice light-sheet microscopy reveals patient specific responses to CD20-directed antibodies in B cell malignancies

An acquired immune-metabolic shift to common chemotherapy confers resistance to immunotherapies in relapsed, high-risk multiple myeloma

Impact of bortezomib on T-cell subsets and immune checkpoints under bispecific antibody therapy in multiple myeloma

Novel insights in therapeutic antibody therapies using advanced microscopy techniques

Upregulation of BCMA expression by selinexor

Elevated NQO1 expression mediates proteasome inhibitor resistance and predicts adverse outcomes in multiple myeloma

Implementing Hifi Sequencing for Enhanced Genomic and Methylome Characterization in Multiple Myeloma

Multi-Omics Analysis of Proteasome Inhibitor Resistance in Multiple Myeloma

GPRC5D Status Impacts CD38 Expression in Multiple Myeloma

Bi-Allelic GPRC5D Alterations Provide Proliferative Advantage in Presence of Talquetamab

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only